Vaseem Mahboob

CIK 1655157 · Chief Financial Officer · last filed 2026-06-04

Vaseem Mahboob is a Chief Financial Officer who has filed 23 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for KMTS, was dated Jun 4, 2026. Across all open-market trades the lifetime net is +$297.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.42M

Companies

3

Total Filings

23

Lifetime Open-Market Net

$297.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KMTS Chief Financial Officer 67,961 $20.85 $1.42M $0 2 2026-06-04
ENDOLOGIX INC /DE/ (ELGX) Delisted Chief Financial Officer 111,716 $297.9K 18 2020-03-26
Insys Therapeutics, Inc. (INSY) Delisted Director 14,083 $0 3 2019-04-23

Recent Filings

23 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-04 KMTS Grant (A) +25,227 $0 EDGAR
2025-07-21 KMTS Grant (A) +22,059 $0 EDGAR
2020-03-26 ENDOLOGIX INC /DE/ (ELGX) Delisted Mixed +43,385 -$3.4K EDGAR
2020-01-02 ENDOLOGIX INC /DE/ (ELGX) Delisted Mixed +43,617 -$5.7K EDGAR
2019-12-17 ENDOLOGIX INC /DE/ (ELGX) Delisted Mixed +44,024 -$7.6K EDGAR
2019-10-01 ENDOLOGIX INC /DE/ (ELGX) Delisted Mixed $0 EDGAR
2019-08-06 ENDOLOGIX INC /DE/ (ELGX) Delisted Grant (A) +32,400 $0 EDGAR
2019-04-23 Insys Therapeutics, Inc. (INSY) Delisted Grant (A) +8,083 $0 EDGAR
2019-04-19 Insys Therapeutics, Inc. (INSY) Delisted Grant (A) +8,083 $0 EDGAR
2019-04-03 ENDOLOGIX INC /DE/ (ELGX) Delisted Mixed +27,628 $100.0K EDGAR
Showing 110 of 23
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.